VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 560 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2015. The put-call ratio across all filers is 2.18 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,605,000 | -19.7% | 9 | 0.0% | 0.00% | – |
| Q2 2015 | $1,999,000 | +11.8% | 9 | 0.0% | 0.00% | – |
| Q1 2015 | $1,788,000 | +38.8% | 9 | 0.0% | 0.00% | – |
| Q4 2014 | $1,288,000 | +9.1% | 9 | 0.0% | 0.00% | – |
| Q3 2014 | $1,181,000 | +4.1% | 9 | 0.0% | 0.00% | – |
| Q2 2014 | $1,135,000 | -100.0% | 9 | -100.0% | 0.00% | -100.0% |
| Q1 2014 | $24,028,127,000 | -32.7% | 182,266 | -40.0% | 3.29% | -33.5% |
| Q4 2013 | $35,681,147,000 | +4.6% | 303,928 | -7.0% | 4.95% | +7.8% |
| Q3 2013 | $34,108,398,000 | +160553.8% | 326,928 | +32.6% | 4.59% | +9.9% |
| Q2 2013 | $21,231,000 | – | 246,643 | – | 4.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |